X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2395) 2395
Publication (113) 113
Book Review (22) 22
Magazine Article (6) 6
Book / eBook (4) 4
Book Chapter (2) 2
Data Set (1) 1
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
male (1694) 1694
humans (1587) 1587
female (1049) 1049
anti-ulcer agents - therapeutic use (1018) 1018
animals (917) 917
anti-ulcer agents - pharmacology (849) 849
adult (763) 763
rats (727) 727
middle aged (671) 671
pharmacology & pharmacy (626) 626
anti-ulcer agents - administration & dosage (526) 526
index medicus (503) 503
gastroenterology & hepatology (487) 487
omeprazole (485) 485
aged (443) 443
gastric mucosa - drug effects (385) 385
proton pump inhibitors (300) 300
omeprazole - therapeutic use (289) 289
stomach ulcer - drug therapy (279) 279
anti-ulcer agents - adverse effects (276) 276
anti-ulcer agents - pharmacokinetics (276) 276
helicobacter infections - drug therapy (266) 266
gastrins - blood (246) 246
helicobacter pylori (242) 242
administration, oral (234) 234
anti-ulcer agents - blood (232) 232
rats, wistar (231) 231
treatment outcome (227) 227
2-pyridinylmethylsulfinylbenzimidazoles (224) 224
lansoprazole (224) 224
gastric mucosa - pathology (220) 220
stomach ulcer - chemically induced (219) 219
omeprazole - analogs & derivatives (213) 213
dose-response relationship, drug (212) 212
omeprazole - administration & dosage (205) 205
drug therapy, combination (202) 202
stomach ulcer - prevention & control (202) 202
omeprazole - pharmacology (195) 195
rats, sprague-dawley (194) 194
time factors (194) 194
double-blind method (190) 190
gastric mucosa - metabolism (189) 189
adolescent (173) 173
pharmacokinetics (173) 173
gastric mucosa - blood supply (171) 171
duodenal ulcer - drug therapy (164) 164
ranitidine (161) 161
anti-bacterial agents - therapeutic use (156) 156
peptic ulcer - drug therapy (151) 151
cross-over studies (150) 150
area under curve (148) 148
stomach ulcer - pathology (148) 148
gastric acid - metabolism (147) 147
ulcers (142) 142
drug interactions (141) 141
mice (135) 135
hydrogen-ion concentration (134) 134
gastric acid - secretion (129) 129
medicine, general & internal (127) 127
omeprazole - pharmacokinetics (126) 126
aged, 80 and over (125) 125
ethanol (122) 122
prospective studies (120) 120
rats, inbred strains (120) 120
therapy (119) 119
disease models, animal (118) 118
risk factors (116) 116
anti-inflammatory agents, non-steroidal - adverse effects (115) 115
omeprazole - adverse effects (114) 114
helicobacter infections - complications (110) 110
peptic ulcer (105) 105
ulcer (105) 105
omeprazole - blood (103) 103
duodenal-ulcer (102) 102
secretion (102) 102
dogs (101) 101
recurrence (101) 101
histamine h2 antagonists - therapeutic use (99) 99
drug administration schedule (96) 96
regional blood flow - drug effects (95) 95
helicobacter pylori - drug effects (94) 94
care and treatment (93) 93
disease (93) 93
ranitidine - therapeutic use (93) 93
follow-up studies (92) 92
cimetidine (90) 90
drug therapy (90) 90
infection (89) 89
proton pump inhibitor (89) 89
rat (89) 89
helicobacter-pylori (88) 88
stomach - drug effects (87) 87
chemistry, medicinal (86) 86
gastric acidity determination (86) 86
indomethacin (86) 86
plant extracts - pharmacology (86) 86
chromatography, high pressure liquid (85) 85
health aspects (85) 85
research (85) 85
double-blind (84) 84
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2174) 2174
Russian (70) 70
Japanese (65) 65
German (23) 23
Chinese (19) 19
French (15) 15
Spanish (13) 13
Italian (8) 8
Ukrainian (8) 8
Polish (4) 4
Danish (2) 2
Korean (2) 2
Arabic (1) 1
Bulgarian (1) 1
Dutch (1) 1
Hebrew (1) 1
Hungarian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2009, Volume 53, Issue 3, pp. 958 - 966
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit... 
CELL TRANSPLANT RECIPIENTS | STEADY-STATE PHARMACOKINETICS | BEVERAGE COCA-COLA | SALVAGE THERAPY | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | FOOD INTERACTION | INVASIVE FUNGAL-INFECTION | ITRACONAZOLE | TRIAZOLE ANTIFUNGAL | VERSUS-HOST-DISEASE | FLUCONAZOLE | Triazoles - administration & dosage | Triazoles - adverse effects | Antifungal Agents - adverse effects | Triazoles - blood | Area Under Curve | Humans | Middle Aged | Omeprazole - blood | Intestinal Absorption - drug effects | Male | Anti-Ulcer Agents - blood | Gastric Mucosa - metabolism | Anti-Ulcer Agents - pharmacokinetics | Dose-Response Relationship, Drug | Young Adult | Antifungal Agents - pharmacokinetics | Hydrogen-Ion Concentration - drug effects | Gastric Mucosa - drug effects | Adult | Female | Triazoles - pharmacokinetics | Suspensions | Eating | European Continental Ancestry Group - genetics | Fasting | Drug Administration Schedule | Administration, Oral | Food-Drug Interactions | Omeprazole - administration & dosage | Anti-Ulcer Agents - adverse effects | African Americans - genetics | European Continental Ancestry Group - statistics & numerical data | Omeprazole - adverse effects | Omeprazole - pharmacokinetics | Carbonated Beverages | Anti-Ulcer Agents - administration & dosage | Cross-Over Studies | African Americans - statistics & numerical data | Antifungal Agents - administration & dosage | Antifungal Agents - blood | Index Medicus | Pharmacology
Journal Article
Annals of Surgery, ISSN 0003-4932, 08/2013, Volume 258, Issue 2, pp. 262 - 269
OBJECTIVE:We conducted a pharmacokinetic (PK) study and a pharmacodynamic (PD) study to assess whether Roux-en-Y gastric bypass (RYGB) surgery is associated... 
furosemide | oral cocktail | CYP3A | gastric bypass | drug metabolism | SURGERY | FATTY LIVER-DISEASE | WEIGHT-LOSS | TRENDS | P-GLYCOPROTEIN | OBESITY | INTESTINAL ADAPTATION | BARIATRIC SURGERY | ABSORPTION | HEPATIC STEATOSIS | Gastric Bypass | Diuretics - pharmacokinetics | Excitatory Amino Acid Antagonists - pharmacokinetics | Humans | Middle Aged | Tolbutamide - urine | Male | Caffeine - pharmacokinetics | Midazolam - urine | Anti-Ulcer Agents - pharmacokinetics | Young Adult | Hypoglycemic Agents - administration & dosage | Aged, 80 and over | Diuretics - urine | Diuretics - administration & dosage | Hypoglycemic Agents - pharmacokinetics | Administration, Oral | Furosemide - pharmacokinetics | Omeprazole - administration & dosage | Excitatory Amino Acid Antagonists - administration & dosage | Hypoglycemic Agents - urine | Omeprazole - urine | Central Nervous System Stimulants - pharmacokinetics | Midazolam - blood | Dextromethorphan - urine | Adolescent | GABA Modulators - urine | Central Nervous System Stimulants - urine | Dextromethorphan - administration & dosage | Furosemide - administration & dosage | Tolbutamide - administration & dosage | Tolbutamide - pharmacokinetics | Caffeine - administration & dosage | Omeprazole - blood | GABA Modulators - pharmacokinetics | Midazolam - administration & dosage | Anti-Ulcer Agents - blood | Chromatography, High Pressure Liquid | Case-Control Studies | Excitatory Amino Acid Antagonists - urine | Hypoglycemic Agents - blood | Tandem Mass Spectrometry | Biotransformation | Adult | Female | Dextromethorphan - pharmacokinetics | Furosemide - urine | Caffeine - urine | Caffeine - blood | GABA Modulators - administration & dosage | GABA Modulators - blood | Omeprazole - pharmacokinetics | Anti-Ulcer Agents - urine | Midazolam - pharmacokinetics | Anti-Ulcer Agents - administration & dosage | Dextromethorphan - blood | Excitatory Amino Acid Antagonists - blood | Tolbutamide - blood | Aged | Central Nervous System Stimulants - blood | Pharmacokinetics | Central Nervous System Stimulants - administration & dosage
Journal Article
Molecular Pharmaceutics, ISSN 1543-8384, 01/2012, Volume 9, Issue 1, pp. 14 - 28
As 95% of all prescriptions are for orally administered drugs, the issue of oral absorption is central to the development of pharmaceuticals. Oral absorption... 
ranitidine | mucoadhesion | hydrophobic drugs | griseofulvin | cyclosporin A | idarubicin | chitosan amphiphiles | hydrophilic drugs | transcellular transport | oral absorption | AQUEOUS-SOLUTIONS | PERMEABILITY | VESICLES | MONOLAYERS | P-GLYCOPROTEIN | DELIVERY | IN-VITRO | TRANSPORT | CYCLOSPORINE-A | EPITHELIAL CACO-2 CELLS | PHARMACOLOGY & PHARMACY | Intestinal Mucosa - metabolism | Nanoparticles - chemistry | Rats, Wistar | Ranitidine - pharmacokinetics | Humans | Drug Carriers - administration & dosage | Idarubicin - pharmacokinetics | Male | Drug Carriers - analysis | Anti-Ulcer Agents - blood | Quaternary Ammonium Compounds - chemistry | Griseofulvin - blood | Intestinal Absorption | Anti-Ulcer Agents - pharmacokinetics | Cyclosporine - blood | Intestinal Mucosa - cytology | Griseofulvin - pharmacokinetics | Griseofulvin - metabolism | Antifungal Agents - pharmacokinetics | Antifungal Agents - metabolism | Cyclosporine - pharmacokinetics | Idarubicin - administration & dosage | Antibiotics, Antineoplastic - pharmacokinetics | Chitosan - analogs & derivatives | Cyclosporine - metabolism | Griseofulvin - administration & dosage | Caco-2 Cells | Idarubicin - metabolism | Drug Carriers - metabolism | Adhesiveness | Nanoparticles - ultrastructure | Rats | Anti-Ulcer Agents - administration & dosage | Ranitidine - metabolism | Antibiotics, Antineoplastic - administration & dosage | Animals | Chitosan - chemistry | Ranitidine - blood | Intestine, Small - cytology | Anti-Ulcer Agents - metabolism | Cyclosporine - administration & dosage | Hydrophobic and Hydrophilic Interactions | Drug Carriers - pharmacokinetics | Intestine, Small - metabolism | Ranitidine - administration & dosage | Antibiotics, Antineoplastic - metabolism | Antifungal Agents - administration & dosage | Antifungal Agents - blood
Journal Article
Journal Article
Journal Article
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 11/2015, Volume 80, Issue 5, pp. 1086 - 1096
AimsMycophenolic acid (MPA) suppresses lymphocyte proliferation through inosine monophosphate dehydrogenase (IMPDH) inhibition. Two formulations have been... 
pantoprazole | pharmacokinetics | immunosuppression | drug–drug interaction | pharmacodynamics | mycophenolic acid | drug-drug interaction | SODIUM | ACID | OMEPRAZOLE | PROTON PUMP INHIBITORS | RECIPIENTS | DRUG EXPOSURE | INTRAGASTRIC PH | 5'-MONOPHOSPHATE DEHYDROGENASE-ACTIVITY | PHARMACOLOGY & PHARMACY | HEALTHY-VOLUNTEERS | MOFETIL | Glucuronides - pharmacokinetics | Enzyme Inhibitors - blood | Humans | Immunosuppressive Agents - pharmacokinetics | Middle Aged | Male | 2-Pyridinylmethylsulfinylbenzimidazoles - pharmacology | Glucuronides - blood | Enzyme Inhibitors - administration & dosage | Drug Interactions | Immunosuppressive Agents - blood | Enzyme Inhibitors - pharmacokinetics | Anti-Ulcer Agents - pharmacology | Female | Mycophenolic Acid - blood | Mycophenolic Acid - administration & dosage | Immunosuppressive Agents - administration & dosage | Mycophenolic Acid - pharmacokinetics | Kidney Transplantation | Anti-Ulcer Agents - administration & dosage | IMP Dehydrogenase - drug effects | Cross-Over Studies | Tablets, Enteric-Coated - pharmacokinetics | Mycophenolic Acid - analogs & derivatives | Immunosuppressive Agents - immunology | Mycophenolic Acid - immunology | 2-Pyridinylmethylsulfinylbenzimidazoles - administration & dosage | Therapeutic Equivalency | Medical research | Kidneys | Metabolites | Immunotherapy | Drug interactions | Singers | Medicine, Experimental | Transplantation | Mycophenolate mofetil
Journal Article
Journal of Clinical Pharmacology, ISSN 0091-2700, 05/2008, Volume 48, Issue 5, pp. 553 - 562
A total of 71 HIV-negative healthy adults were randomized to 1 of 6 regimens to receive lopinavir/ritonavir tablets 400/100 mg twice daily (bid) or 800/200 mg... 
Atazanavir | Pharmacokinetics | Acid-reducing agents | Ritonavir | Lopinavir | acid-reducing agents | lopinavir | EFFICACY | atazanavir | ritonavir | pharmacokinetics | VALIDATION | PHARMACOLOGY & PHARMACY | CLINICAL PHARMACOKINETICS | PROTEASE INHIBITORS | Area Under Curve | Ranitidine - pharmacokinetics | Humans | Middle Aged | Pyridines - pharmacokinetics | Biological Availability | Male | Anti-HIV Agents - administration & dosage | Anti-Ulcer Agents - pharmacokinetics | Dose-Response Relationship, Drug | Histamine H2 Antagonists - administration & dosage | Drug Interactions | HIV Protease Inhibitors - pharmacokinetics | Atazanavir Sulfate | Adult | Female | Ranitidine - adverse effects | Anti-HIV Agents - blood | HIV Protease Inhibitors - blood | Pyridines - administration & dosage | Oligopeptides - blood | Ritonavir - administration & dosage | Ritonavir - blood | Oligopeptides - pharmacokinetics | Omeprazole - administration & dosage | Anti-Ulcer Agents - adverse effects | Histamine H2 Antagonists - adverse effects | Omeprazole - adverse effects | Omeprazole - pharmacokinetics | HIV Protease Inhibitors - administration & dosage | Histamine H2 Antagonists - pharmacokinetics | Anti-Ulcer Agents - administration & dosage | Pyridines - blood | Pyrimidinones - pharmacokinetics | Ritonavir - pharmacokinetics | Pyrimidinones - blood | Anti-HIV Agents - pharmacokinetics | Oligopeptides - administration & dosage | Pyrimidinones - administration & dosage | Ranitidine - administration & dosage | Antiviral agents | Dosage and administration | Research | Drug interactions | Index Medicus
Journal Article
Journal of International Medical Research, ISSN 0300-0605, 6/2018, Volume 46, Issue 6, pp. 2436 - 2444
Objective To investigate the effects of polaprezinc (PZ) on cyclophosphamide (CTX)- or cisplatin (DDP)-induced gastric mucosal injury and on a rat model of... 
5-hydroxytryptamine | cancer chemotherapy | nuclear factor kappa B | Polaprezinc | cyclophosphamide | cisplatin | dopamine | MEDICINE, RESEARCH & EXPERIMENTAL | EMETOGENIC CHEMOTHERAPY | PROTECTION | PREVENTION | CANCER | ZINC | NAUSEA | PHARMACOLOGY & PHARMACY | PALONOSETRON | MICE | L-CARNOSINE | EXPRESSION | Intestine, Small - pathology | Dopamine - blood | Gastric Mucosa - pathology | Male | Carnosine - therapeutic use | Cyclophosphamide - adverse effects | Intestinal Mucosa - drug effects | Carnosine - analogs & derivatives | Serotonin - blood | Zinc Compounds - pharmacology | Antineoplastic Agents - adverse effects | Gastric Mucosa - drug effects | Organometallic Compounds - therapeutic use | Anti-Ulcer Agents - pharmacology | Intestine, Small - injuries | Zinc Compounds - therapeutic use | Dopamine - analysis | Disease Models, Animal | NF-kappa B - analysis | Anti-Ulcer Agents - therapeutic use | NF-kappa B - blood | Serotonin - analysis | Rats | Carnosine - pharmacology | Rats, Sprague-Dawley | Neurotransmitter Agents - blood | Vomiting - chemically induced | Animals | Intestine, Small - drug effects | Brain - pathology | Cisplatin - adverse effects | Brain Chemistry | Intestinal Mucosa - injuries | Vomiting - pathology | Gastric Mucosa - injuries | Neurotransmitter Agents - analysis | Organometallic Compounds - pharmacology | Intestinal Mucosa - pathology | Pre-Clinical Research Reports
Journal Article
Journal Article
Journal Article